Compassionate Mind Training for Women Going Through Menopause
The Feasibility and Effects of Group Compassionate Mind Training for Adults Experiencing the Menopause Transition: a Preliminary Investigation
This study is testing if group sessions that teach self-compassion can help women aged 40-60 feel better and cope with mood and anxiety issues during menopause.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 40 Years to 60 Years |
| Sex | Female |
| Sponsor | University College, London Academic / other |
| Locations | 1 site (London, County) |
| Trial ID | NCT06462157 on ClinicalTrials.gov |
What this trial studies
This study focuses on providing group-based Compassionate Mind Training (CMT) to women aged 40-60 who are experiencing symptoms of menopause or peri-menopause. CMT aims to enhance self-compassion and reduce feelings of self-criticism, which can exacerbate menopausal symptoms such as low mood and anxiety. Participants will engage in sessions designed to improve their mental well-being and coping strategies during this transitional phase. The study will assess the effectiveness of CMT in alleviating depressive and anxiety symptoms associated with menopause.
Who should consider this trial
Good fit: Ideal candidates are biologically female adults aged 40-60 experiencing menopausal symptoms and who are willing to participate in group sessions.
Not a fit: Patients who are under 40, more than 5 years post-menopause, or currently receiving psychological interventions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the mental health and quality of life for women undergoing menopause.
How similar studies have performed: Previous studies have shown promise for psychological interventions like CMT in managing menopause symptoms, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (aged 40-60) who are biologically female * Women who are experiencing symptoms of the menopause or peri-menopause; which is naturally occurring. This is identified through the STRAW criteria. Individuals have to answer Yes on at least one of the STRAW screening questions to ensure women are in the perimenopause or menopausal period. * Substantial English verbal communication and comprehension skills * Capacity to consent * Confident in using video conferencing applications (MsTeams) * Willingness to take part in a post-intervention interview about their experience. * PHQ-9 score 5-19 (mild to moderate clinical cut offs) * GAD-7 score 5-15 (mild to moderate clinical cut offs) Exclusion Criteria: * People under the age of 40 * People currently receiving any form of psychology intervention. * Transgender females who are biologically male * More than 5 years post menopause. * PHQ-9 score greater or equal to 20 (severe clinical cut off) * GAD-7 score greater or equal to 15 (severe clinical cut off)
Where this trial is running
London, County
- University College London — London, County, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Aimee Spector — Ucl
- Study coordinator: Aimee Spector
- Email: a.spector@ucl.ac.uk
- Phone: 020 7679 1844
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.